Vision changes: Individuals with diabetes should monitor for changes in eyesight, as blood sugar fluctuations can affect vision
Filip Krag Knop has served on scientific advisory panels and/or been part of speakers bureaus for, served as a consultant to, and/or received research support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Carmot Therapeutics, Eli Lilly, Gubra, MedImmune, MSD/Merck, Mundipharma, Norgine, Novo Nordisk, Sanofi, and Zealand Pharma
Tirzepatide is a dual GIP/GLP-1 receptor agonist that slows gastric emptying and reduces appetite, which may affect protein tolerance
Think of it like filling a bathtub with a slow drain
They cannot monitor for complications or adjust treatment appropriately if they do not know what you are taking